Page last updated: 2024-11-05

allyl bromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7841
CHEMBL ID1429506
SCHEMBL ID411
MeSH IDM0143999

Synonyms (68)

Synonym
3-bromo-prop-1-ene
106-95-6
3-bromo-1-propene
allyl bromide
wln: e2u1
2-propenyl bromide
1-propene, 3-bromo-
1-bromo-2-propene
3-bromopropene
nsc7596
bromallylene
3-bromopropylene
propene, 3-bromo-
nsc-7596
3-bromoprop-1-ene
inchi=1/c3h5br/c1-2-3-4/h2h,1,3h
NCGC00091515-01
einecs 203-446-6
ccris 9049
hsdb 622
un1099
ai3-52208
brn 0605308
nsc 7596
allyl bromide, reagentplus(r), 99%, contains <=1000 ppm propylene oxide as stabilizer
allyl bromide, reagent grade, 97%, contains <=1000 ppm propylene oxide as stabilizer
B0643
AKOS000118756
NCGC00091515-02
NCGC00258355-01
cas-106-95-6
tox21_200801
dtxcid204442
dtxsid8024442 ,
allylbromide
un 1099
ec 203-446-6
fxq8x2f74z ,
unii-fxq8x2f74z
allyl bromide [un1099] [flammable liquid]
FT-0615127
BR1119
SCHEMBL411
allyl bromide [mi]
allyl bromide [hsdb]
3-bromo-1-propen
allyl-bromide
allylbromid
1-brom-2-propene
allyl bromine
3-bromo-propene
CHEMBL1429506
ch2=chch2br
STR00178
mfcd00000244
J-001680
J-519554
F2190-0178
allyl bromide, 99%, stab. with 300-1000ppm propylene oxide
allyl bromide, puriss., >=99.0% (gc)
allyl bromide, purum, >=98.0% (gc)
BP-13477
Q223062
STL199163
3-bromopropene allyl bromide
allyl bromide (stabilized with propylene oxide)
EN300-19278
allyl-d5bromide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The survival and mean body weights of all dosed groups of males and females were similar to those of the vehicle controls."( Toxicology studies of allyl bromide (CAS No. 106-95-6) in genetically modified (FVB Tg.AC hemizygous) mice and carcinogenicity studies of allyl bromide in genetically modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] mice (dermal and gavage studies).
, 2008
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.01820.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency81.36210.000221.22318,912.5098AID743042
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
estrogen nuclear receptor alphaHomo sapiens (human)Potency58.12890.000229.305416,493.5996AID743069
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency56.23410.001019.414170.9645AID588536
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (16.22)18.7374
1990's0 (0.00)18.2507
2000's9 (24.32)29.6817
2010's22 (59.46)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.87 (24.57)
Research Supply Index3.66 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index92.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (57.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]